Edward Cox is CEO of Dthera™ Sciences, the leading digital therapeutic company focusing on the elderly and individuals with neurodegenerative diseases, based in San Diego, CA. This summer they gained FDA breakthrough designation for their development-stage product, DTHR-ALZ for the symptoms of Alzheimer’s. We sat down with Ed to find out what this means and where he thinks things are headed for the rapidly advancing digital therapeutic products sector.
Read More
